[go: up one dir, main page]

Zhang et al., 2021 - Google Patents

Microfluidics for sepsis early diagnosis and prognosis: a review of recent methods

Zhang et al., 2021

Document ID
2145811444935342213
Author
Zhang Y
Zhou Y
Yang Y
Pappas D
Publication year
Publication venue
Analyst

External Links

Snippet

Sepsis is a complex disorder of immune system response to infections that can be caused by a wide range of clinical contexts. Traditional methods for sepsis detection include molecular diagnosis, biomarkers either based on protein concentration or cell surface …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N2015/0065—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood

Similar Documents

Publication Publication Date Title
Jayamohan et al. SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations
Tribolet et al. MicroRNA biomarkers for infectious diseases: from basic research to biosensing
Oeschger et al. Point of care technologies for sepsis diagnosis and treatment
Zhang et al. Detection of pathogenic microorganisms by microfluidics based analytical methods
Larsen et al. Novel biomarkers for sepsis: A narrative review
Fan et al. Diagnosing sepsis–The role of laboratory medicine
Kolluri et al. Towards lab-on-a-chip diagnostics for malaria elimination
Ohlsson et al. Integrated acoustic separation, enrichment, and microchip polymerase chain reaction detection of bacteria from blood for rapid sepsis diagnostics
Mitsuma et al. Promising new assays and technologies for the diagnosis and management of infectious diseases
Tang et al. Capillary blood for point-of-care testing
Kim et al. Current advances in paper-based biosensor technologies for rapid COVID-19 diagnosis
Zhang et al. Microfluidics for sepsis early diagnosis and prognosis: a review of recent methods
Chin et al. Low-cost microdevices for point-of-care testing
Abasıyanık et al. Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes
Kalyan et al. Inertial microfluidics enabling clinical research
Jamiruddin et al. Microfluidics technology in SARS-CoV-2 diagnosis and beyond: a systematic review
Alba-Patiño et al. Micro-and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care
Jiang et al. Microfluidic detection of human diseases: From liquid biopsy to COVID-19 diagnosis
Yin et al. Microfluidics-based POCT for SARS-CoV-2 diagnostics
US12013396B2 (en) Microdevice for cell separation utilizing activation phenotype
EP2156376A1 (en) Methods for counting cells
Cui et al. Reagent free detection of SARS-CoV-2 using an antibody-based microwave sensor in a microfluidic platform
Valera et al. Electrochemical point-of-care devices for the diagnosis of sepsis
Mou et al. Point-of-care immunoassays with tunable detection range for detecting infection in intensive care unit
Fukana et al. Magnetophoretic slider assay for electrochemical detection of SARS-cov-2 nucleocapsid protein in nasal swab samples